Skip to main content
Journal cover image

Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease.

Publication ,  Journal Article
Mühlbacher, A; Johnson, FR; Yang, J-C; Happich, M; Belger, M
Published in: Value Health
January 2016

OBJECTIVE: The diagnosis of Alzheimer's disease (AD) remains difficult. Lack of diagnostic certainty or possible distress related to a positive result from diagnostic testing could limit the application of new testing technologies. The objective of this paper is to quantify respondents' preferences for obtaining AD diagnostic tests and to estimate the perceived value of AD test information. METHODS: Discrete-choice experiment and contingent-valuation questions were administered to respondents in Germany and the United Kingdom. Choice data were analyzed by using random-parameters logit. A probit model characterized respondents who were not willing to take a test. RESULTS: Most respondents indicated a positive value for AD diagnostic test information. Respondents who indicated an interest in testing preferred brain imaging without the use of radioactive markers. German respondents had relatively lower money-equivalent values for test features compared with respondents in the United Kingdom. CONCLUSIONS: Respondents preferred less invasive diagnostic procedures and tests with higher accuracy and expressed a willingness to pay up to €700 to receive a less invasive test with the highest accuracy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Value Health

DOI

EISSN

1524-4733

Publication Date

January 2016

Volume

19

Issue

1

Start / End Page

66 / 74

Location

United States

Related Subject Headings

  • United Kingdom
  • Socioeconomic Factors
  • Radiation Exposure
  • Patient Preference
  • Middle Aged
  • Humans
  • Health Policy & Services
  • Germany
  • Diagnostic Techniques and Procedures
  • Cross-Cultural Comparison
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mühlbacher, A., Johnson, F. R., Yang, J.-C., Happich, M., & Belger, M. (2016). Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease. Value Health, 19(1), 66–74. https://doi.org/10.1016/j.jval.2015.10.011
Mühlbacher, Axel, F Reed Johnson, Jui-Chen Yang, Michael Happich, and Mark Belger. “Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease.Value Health 19, no. 1 (January 2016): 66–74. https://doi.org/10.1016/j.jval.2015.10.011.
Mühlbacher A, Johnson FR, Yang J-C, Happich M, Belger M. Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease. Value Health. 2016 Jan;19(1):66–74.
Mühlbacher, Axel, et al. “Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease.Value Health, vol. 19, no. 1, Jan. 2016, pp. 66–74. Pubmed, doi:10.1016/j.jval.2015.10.011.
Mühlbacher A, Johnson FR, Yang J-C, Happich M, Belger M. Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease. Value Health. 2016 Jan;19(1):66–74.
Journal cover image

Published In

Value Health

DOI

EISSN

1524-4733

Publication Date

January 2016

Volume

19

Issue

1

Start / End Page

66 / 74

Location

United States

Related Subject Headings

  • United Kingdom
  • Socioeconomic Factors
  • Radiation Exposure
  • Patient Preference
  • Middle Aged
  • Humans
  • Health Policy & Services
  • Germany
  • Diagnostic Techniques and Procedures
  • Cross-Cultural Comparison